Evidence map›Paper›PMID 42128887›Full record

ArticleNature communications2026

Base modifications shift tertiary structure and activity in synthetic RNA origami and a natural ribozyme.

Deepak Kumar Yadav, Haoyun Yang, Sukyeong Lee, Ewan K S McRae

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Deepak Kumar Yadav *Houston Methodist Research Institute (HMRI), Houston, TX, USA.ORCID http://orcid.org/0000-0002-4555-3851
Haoyun Yang *Houston Methodist Research Institute (HMRI), Houston, TX, USA.ORCID http://orcid.org/0000-0002-5307-5079
Sukyeong LeeVerna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6054-6628
Ewan K S McRaeHouston Methodist Research Institute (HMRI), Houston, TX, USA. ekmcrae@houstonmethodist.org.ORCID http://orcid.org/0000-0001-9105-2575

Funding

ACQUISITION OF HIGH-THROUGHPUT 200 kV CRYO-TEMS10OD032204 · OD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SERYSHEVA, IRINA I · 2022 to 2022
$2.0M
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR230015NIH HHS S10 OD032204
6 · The paper itself

Abstract

Modified nucleotide bases like 5-methylcytosine (m5C) and N1-methyl-pseudouridine (m1Ψ) are widely used to enhance stability and reduce immunogenicity in therapeutic RNAs, yet their impact on RNA tertiary structure remains unclear. Here we investigate how these modifications influence folding and function in both a synthetic RNA origami nanostructure and the natural Tetrahymena ribozyme. Using cryo-EM, FRET, and biochemical assays, we find that modified bases impede proper maturation of RNA origami by stabilizing alternative coaxial stacking at key junctions, leading to dimerization. In the ribozyme, modifications shift the equilibrium between open and closed conformations, altering catalytic activity in a temperature-dependent manner. These effects arise primarily from changes in base-stacking energetics rather than base pairing. Our findings reveal that base modifications reshape RNA folding landscapes and structure-function relationships, underscoring the need to consider structural consequences when designing modified RNAs for synthetic biology and therapeutic applications.

Indexed as

Nucleic Acid ConformationRNARNA, Catalytic5-MethylcytosineBase PairingBase SequenceCryoelectron MicroscopyFluorescence Resonance Energy TransferModels, MolecularPseudouridineRNA FoldingTetrahymena5-MethylcytosinePseudouridineRNARNA, Catalytic

Identifiers

PMID42128887
PMCPMC13376386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.